Assistant Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Cardiology
Dr. Antonio Abbate, MD
|
|
Give Review
Dr. Antonio Abbate works in the field of Cardiology. He received 1 awards: "Whos Who in Medicine and Healthcare". Antonio Abbate is also a published doctor. He has 57 publication published. The most recent publication is: Recombinant Human Alpha-1 Anti-Trypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury Following Ischemia Reperfusion Independent Of Elastase Inhibition. He is registered with Medicare.
Publications
- Recombinant Human Alpha-1 Anti-Trypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury Following Ischemia Reperfusion Independent Of Elastase Inhibition.
- Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase.
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse.
- Interleukin-1 Blockade In Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.
- Relaxin' the Heart: A Novel Therapeutic Modality.
- A model of acute kidney injury in mice with cirrhosis and infection.
- Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.
- A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice.
- Thoracic Sympathectomy for Severe Refractory Multivessel Coronary Artery Spasm.
- Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure.
- Noncompliance and cessation of dual antiplatelet therapy after coronary stenting: looking at the speck rather than noticing the log?
- Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.
- Inflammatory markers in ST-elevation acute myocardial infarction.
- Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction (from the VC...
- Heart failure with preserved ejection fraction: Refocusing on diastole.
- Aspirin underuse, non-compliance or cessation: Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease.
- Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo.
- Diastolic dysfunction in chronic hypoxia: IL-18 provides the elusive link.
- Targeting Interleukin-1 in Heart Failure and Inflammatory Heart Disease.
- The Inflammasome in Myocardial Injury and Cardiac Remodeling.
- Iloprost reverses established fibrosis in experimental right ventricular failure.
- Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
- Interleukin-1β blockade improves left ventricular systolic/diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse.
- A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era.
- Treatment of group I pulmonary arterial hypertension with carvedilol is safe.
- Induction of MicroRNA-21 with Exogenous Hydrogen Sulfide Attenuates Myocardial Ischemic and Inflammatory Injury in Mice.
- Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
- Life-saving systemic thrombolysis in a patient with massive pulmonary embolism and a recent hemorrhagic cerebrovascular accident.
- Dual anti-platelet therapy after drug-eluting stent implantation: when is 'enough' enough?
- Clinical predictors of response to anakinra in patients with heart failure.
- Interleukin-10 in patients with ST-segment elevation myocardial infarction.
- Interleukin-1 blockade in rheumatoid arthritis and heart failure: A missed opportunity?
- Formation of the inflammasome in acute myocarditis.
- Interleukin-18 mediates Interleukin-1-induced cardiac dysfunction.
- Anti-inflammatory strategies for ST-elevation acute myocardial infarction ventricular remodeling.
- A NOVEL PHARMACOLOGIC INHIBITOR OF THE NLRP3 INFLAMMASOME LIMITS MYOCARDIAL INJURY FOLLOWING ISCHEMIA-REPERFUSION IN THE MOUSE.
- Targeting interleukin-1 in heart disease.
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study).
- Role of NLRP3 (cryopyrin) in acute myocardial infarction.
- Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse.
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth Unive...
- Benefits of ? blockers in patients with heart failure and reduced ejection fraction: network meta-analysis.
- Mechanisms of right heart failure-A work in progress and a plea for failure prevention.
- Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats.
- GS-6201, a Selective Blocker of the A2B Adenosine Receptor, Attenuates Cardiac Remodeling after Acute Myocardial Infarction in the Mouse.
- Pathobiology of pulmonary arterial hypertension and right ventricular failure.
- Interleukin-1β immunoneutralization improves cardiac remodeling after myocardial infarction without interrupting the inflammasome in the mouse.
- Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy due to Pulmonary Arterial Hypertension.
- Galectin-1 Controls Cardiac Inflammation and Ventricular Remodeling during Acute Myocardial Infarction.
- Inhibition of apoptosis signal-regulating kinase 1 reduces myocardial ischemia-reperfusion injury in the mouse.
- Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events.
- Recombinant Human Interleukin-1 Receptor Antagonist Provides Cardioprotection During Myocardial Ischemia Reperfusion in the Mouse.
- Sympathectomy as a treatment for refractory coronary artery spasm.
- Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure.
- Increased eicosanoid levels in the sugen/chronic hypoxia model of severe pulmonary hypertension.
- A Network Meta-Analysis on Randomized Trials Focusing on the Preventive Effect of Statins on Contrast-Induced Nephropathy.
Schools
University Campus Bio Medico
Virginia Commonwealth University
Catholic University
Doctors Specialties
- Internal Medicine
- Cardiology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
Virginia Commonwealth University Health System
Drug Facts
| NPI NUMBER | 1184849168 | |
| NPPES Provider LastName | ABBATE | |
| NPPES Provider FirstName | ANTONIO | |
| NPPES Provider ZIPCode | 232985051 | |
| NPPES Provider State | VA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 463.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184849168 |
| Last Name Of The Provider | ABBATE |
| First Name Of The Provider | ANTONIO |
| View All |
Similar Doctors
|
|
Dr. James A. Arrowood, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hem L. Bhardwaj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Witherspoon, MD |
|
|
Dr. Leslie W. Rose III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ralph R. Clark III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles H. Robertson Jr., MD |
|
|
Dr. Wilhelmina N. Estrada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alice Wong, MD |
|
Dr. Martin D. Caplan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George W. Vetrovec, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Keyur B. Shah, MD |
|
|
Dr. Michael L. Hess, MD |
|
|
Dr. Jose F. Huizar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. Lesnefsky Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Richardson, MD |
|
|
Dr. Andrea F. Tordini, MD |